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1. Introduction 
Adaptations, conservation or evolution of physiological systems in human indicates that the  
physiological system for hypoxia tolerance represents an adaptive character that is present 
in humans, just like in poikilotherms or endotherms(Hochachka 1993; Hochachka et al. 
1996). Precisely, brain metabolic organization capability is thought to represent an adaptive 
physiological system that is present in humans, but composed of so many neurochemical 
products and physiological mechanisms  that make it difficult to account for its plasticity  
for manipulation to induce  protection(Hochachka 1993; Frappell et al. 2002). Evidence that 
hypoxia tolerating mammals  suppressed metabolic demand in response to hypoxia 
contributed substantially to the understanding  of metabolic regulation as a neuroprotective 
strategy that can be adapted for the protection of tissue hypoxia in humans. In that case,  
understanding the physiological mechanisms that are involved in such ability in hypoxia 
tolerating species may provide a clue for specific mechanisms that could be manipulated in 
the brain of stroke patients to prevent the death of metabolically vulnerable neurons. In this 
context, knowledge of  the specific role of the central neurotransmitter systems and 
pathways that control metabolic suppression  during  hypoxia tolerance is important. This is  
because the neurochemical-mediators that may defend against hypoxic insults during  brain 
injury act through  interconnections within the neural systems that are highly protected in 
hypoxia tolerating species(Mravec et al. 2006). Exposure of non hypoxia tolerating species to  
severe hypoxia results in the alteration of the connections within the neural systems because 
of loss control of  local  microcirculation of oxygen. This leads to ineffectiveness  of  
membrane potentials  to modulate neuronal function (Ackland et al. 2007). If this occurs,  
there is some hope for effective neuropharmacological intervention through 
neurotransmitter-mediators. The fact that chemical neurotransmitters are part of normal 
physiology, whether during development or adulthood, means that specific agonists and 
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antagonists that restore physiological  homeostasis can lead to pharmacological repair of 
hypoxia-induced neuronal damage in humans.  
2. Physiological strategies that protect the brain during ischemic stroke 
Hypothermia is one strategy that can  decrease hypoxic/ischemic injury under regulated 
conditions (Rincon 2008; Statler 2008). This is possible because a  decline in brain 
temperature can prevent the dead of  neurons that are deprived of nutrients. Such a 
protective strategy has been attributed to the  reversible protein phosphorylation that   
regulates suppression of the rates of multiple ATP-production, ATP-utilization and related 
cellular processes that allow animals to go through a stable hypometabolic state (Storey and 
Storey 2007; Storey and Storey 2005). A stable hypometabolic state mechanism is known to 
protect against pathological effects of cortical neuronal pathology or oxidative stress in 
stroke patients (Ma et al. 2005). Cumulative evidence from  studies of  hypometabolism 
during hibernation in small mammals suggests that hypometabolism is  a stable metabolic 
state that allows  timely limited  energy regulation during hypoxia (Heldmaier et al. 2004). 
This is because a stable metabolic state  activates  defense mechanisms, such as antioxidants, 
proteins, protease inhibitors that stabilize macromolecules and promote long-term neuronal 
viability in the stable metabolic state (Zhou et al. 2001; Zhao and Zuo 2005). These 
adaptations   can be manipulated in humans to  prevent the death of metabolically 
vulnerable neurons in stroke patients. Although these adaptations do not fully account for  
the mechanisms that facilitate  the suppression of metabolism during exposure to hypoxia 
(Nathaniel et al. 2009) or during mammalian hibernation (Drew et al. 2007), it has been 
proposed that hypoxia itself could facilitate a systematic regulation of  metabolism through 
cooling of core body temperature and stabilization of temperature in the new metabolic rate 
(Barros et al. 2001). Future studies that explore the mechanisms that switch-off energy 
demand, when supplies become limited during metabolic suppression could provide clues 
of how to develop metabolic suppression as novel therapy in the clinical management of 
stroke.  
3. Cellular implications of disruption of brain energy balance when oxygen 
delivery fails to meet demand  
The mammalian brain is a highly oxidative organ that accounts for an inexplicably large 
percentage of the whole body oxygen consumption that provides the major source of energy 
during aerobic metabolism (Wang et al. 2002). This implies that structural and functional 
integrity of brain functions strongly depend on a regular oxygen and glucose supply. 
Therefore, any disruption of the homeostasis of brain energy demand and supply becomes 
life threatening. This is because a reduction in oxygen availability due to the abnormality in 
systemic or local blood circulation cannot be endured for a prolonged period by a non 
hypoxia tolerant species (Zhou et al. 2001a; Barger et al. 2003). The immediate effect is 
variation in oxygen partial pressure (PO2), within the brain that is detected by cellular 
oxygen sensors. The cellular oxygen sensors, such as hypoxia inducible transcription factors 
(HIFs), are thought to be available to regulate oxygen homeostasis in the brain. In order for 
the brain to cope with variations in oxygen partial pressure, these sensors induce adaptive 
mechanisms to avoid, or at least minimize, brain damage (Nawashiro et al. 1996). Any 
abnormality in cellular oxygen-sensor response is a reflection of the low partial pressure and 
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concentrations of oxygen in the brain. The abnormality is primarily because of the inability 
of a specific oxygen-sensor or target system  to tailor adaptive responses according to 
differences in the cellular oxygen availability in a short or long term. In this context, the 
arising question is how does low cellular oxygen availability affect neuronal and 
physiological activities? Major cellular operations in the brain are dependent on the oxygen 
level in the physiological range (Erecinska et al. 2005). Limitation of oxygen supply to the 
brain below a critical physiological level blocks oxidative phosphorylation, which 
drastically decreased cellular ATP leading to a collapse in ion gradients. Consequently, 
neuronal activity stops. If the process of re-oxygenation is not re-introduced quickly, 
neurons will die(Nawashiro et al. 1996). In  the brain of a stroke patient, early interruption 
of energy homeostasis when oxygen delivery fails to meet oxygen demand is the first step in 
a surge of events that leads to cell death of metabolically susceptible neurons. If hypoxia 
does not set in, availability of glucose will help maintain ATP levels through glycolysis. 
However, if glucose supply is limited, reduction of high-energy phosphates (e.g. ATP) 
results in loss of cellular ionic homeostasis (Erecińska and Silver 2001). This is because the 
disruption of ion homeostasis causes an influx of Na+ and Cl– ions, the release of 
neurotransmitters, opening of voltage-gated Ca2+ channels, and anoxic depolarization 
(Erecinska et al. 2005). This finding suggests that anoxic depolarization is directly associated 
with hypoxia-induced neuronal loss that leads to irreversible brain damage. An interesting 
question relevant to this idea is how does anoxic depolarization trigger neuronal death 
during hypoxia? This question has been investigated in the context of the mechanism of 
anoxic depolarization. For instance, concurrent changes in (K+)0t that lead to  failure of (Na+ 
,K+) ATPase occur during hypoxia due to ATP depletion(Balestrino et al. 1989). In support of 
this idea, electrophysiological evidence reveals that failure of ATPase causes anoxic 
depolarization through some intermediate event, such as Na+-induced cell swelling(Rufini 
et al. 2009). To clarify the direct relationship between anoxic depolarization and ATP levels, 
synaptic transmission analysis  in rat hippocampus revealed that first, Na+ influx plays a 
relatively larger role in ATP consumption during hypoxia than Ca2+ influx; second, anoxic 
depolarization imposes a large and rapid drop in ATP levels(Fowler et al. 1999). Taken 
together, it then implies that depolarization and increased sodium concentration during 
hypoxia seem to account for a significant portion of the neuronal damage induced by 
hypoxia that eventually leads to both necrotic and apoptotic processes (Reshef et al. 2000; 
Gonchar and Mankovskaya 2009). 
4. Stimulation of glutamate, activation of NMDA and AMPA receptors regulate 
calcium influx and promote neuronal damage 
Although  increased sodium concentration during hypoxia seems to account for a major part 
of  neuronal damage during hypoxia,  additional structural damages develop hours or days 
later because Ca2+ influx into neurons is  stimulated by glutamate (He et al. 2009), and 
amplified by activation of NMDA and AMPA receptors (Zamalloa et al. 2009). Glutamate is 
one of the most widespread excitatory neurotransmitters in the brain. In small amounts, it is 
indispensable for neuronal function, while in excessive amounts it is a neuronal poison 
(excitotoxin) that stimulates Ca2+ influx into neurons (Liljequist et al. 1995; Bonde et al. 
2005). If the excessive extracellular release of glutamate is not regulated, it could lead to 
brain damage(Robinson 2006). This idea is strengthened by the observation  that 
overstimulation of glutamate receptors promotes neuronal death(Sheldon and Robinson 
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2007a). Since excessive glutamate is harmful to the brain, how exactly can excess amounts of 
glutamate be regulated in the brain cells? It is possible that such regulation could be 
achieved by controlling a specific effector system that modulates the activities of glutamate. 
In support of this idea, studies by Pellegrini-Giampietro et al.(1999), Sheldon and Robinson 
(2007a) suggest that the mechanism that regulates glutamate transporter activity within 
minutes is a major redistributor of  proteins in the plasma. This idea is further strengthened 
by the finding that glutamate transporters are regulated by the mechanism that redistributes 
proteins to or from the plasma membrane(Savolainen et al. 1995; Noda et al. 2000; Sheldon 
and Robinson 2007b). Findings from these studies  indicate that longer-term activation of 
protein kinase C (PKC) decreased the activity and cell surface expression of the 
predominant forebrain glutamate Glu-1 transporter that is being redistributed from the 
plasma membrane to an intracellular compartment. Taken together, the existing studies 
reveal that the cellular machinery required for redistribution is via lysosomal degradation 
and not proteosomal degradation. Since longer-term activation of PKC results in 
degradation of GLT-1 that can be  blocked by inhibitors of lysosomal but not proteosomal 
degradation, we speculate that regulation of total GLT-1 levels during hypoxia could play a 
significant role in hypoxia neuroprotection. Since the stimulative effect of glutamate (Noda 
et al. 2000) and activation of NMDA and AMPA receptors (Sobczyk et al. 2005) led to 
calcium overload (Mulvey and Renshaw 2009), our interest in this review to determine 
whether the different roles of glutamate, NMDA and AMPA receptors are the sole means of 
extracellular accumulation of calcium following hypoxic insults. By analyzing the influence 
of a specific ion channel inhibitor on the rise of cytosolic free calcium (Ca2+) during hypoxia 
in a  rat’s cerebrocortical brain slices, Bickler (1998) found that the cytosolic calcium changes 
during hypoxia  are due to multiple mechanisms. The changes are incompletely inhibited by 
a combined ion channel blockade. They are associated with the disruption of the cell 
membrane integrity. There is evidence that other factors may be at work as well. One factor 
is oxidative stress that is associated with the activation of microglia. Activation of microglia 
in turn, releases inflammatory cytokines, nitric oxide and extracellular accumulation of 
calcium, resulting in stress and neuronal death. Another factor is an increase in reactive 
oxygen species production. This alters cellular components including calcium levels and 
contributes to cytotoxic events that lead to cell death.  
5. Cellular responses in brain neural systems can help in understanding 
hypoxia-induced hypometabolism and neuroprotection 
In the previous section, we described how the stimulation of glutamate, activation of 
NMDA and AMPA receptors can regulate calcium influx and promote neuronal damage. It 
is now important to discuss how cellular responses in brain neural systems can help in 
understanding hypoxia-induced hypometabolism to initiate neuroprotection. Obviously, 
this proposal needs an explanation on how the cellular responses in any brain neural 
network would be a major factor for understanding hypoxia-induced hypometabolism and 
functional integrity. Indeed, a correlative neurophysiological observation tells us that 
understanding hypometabolism during  neuroprotection should be in the context of 
functional integrity, because hypoxic response of each neuron can be unexpectedly 
heterogeneous, even within the same brain region(Boutilier 2001). The heterogeneity might 
be due to the fact that hypoxia itself leads to considerable downregulation of ion channels 
inside the brain neuronal systems, such that hypoxic reaction of individual neurons vary 
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(Pena and Ramirez 2005). The variation, in turn, may help in maintaining functional 
integrity. The idea is supported by the observation that ion channel arrest does not lead to 
the shutdown of entire networks, nor can networks operate by all cellular components 
entering a general hypometabolic-neuroprotective state(Ramirez et al. 2007). For instance, a 
general shutdown of NMDA or Ca2+ dependent processes would not be beneficiary to a 
hypoxia tolerating animal in a hypometabolic state. This is because such a shutdown would 
severely compromise higher-brain functions. Therefore, hypoxia research should focus on 
understanding mechanisms of  hypometabolism during  neuroprotection in the context of 
functional integrity, and as expressed by hypoxia tolerating species. This disconnect may 
explain why the protection against tissue hypoxia during stroke is still a main medical 
problem. There is no doubt that activation of NMDA receptors or intracellular Ca2+ may 
lead to necrosis and apoptosis. However, restraining these mechanisms is not very helpful 
because they also affect neuroprotection. Taken together, understanding  how hypoxia-
tolerant neurons sense changes in oxygen dynamics and create signals that have instant and 
long-term effects on neuronal survival will be significant in developing new strategies for 
neuroprotection. Studies of how metabolism is regulated at cellular levels during which 
energy-producing and energy-consuming processes are balanced, facilitated by 
neurotransmitters-mediated mechanism would be of considerable interest. Since many of 
the existing studies support the idea that adenosine  induces neuroprotection during  
hypoxia, we will now focus on the different physiological and molecular mechanisms used 
by adenosine  in inducing protection in natural systems of hypoxia tolerance.  
6. Adenosine induces neuroprotection by mediating ion signaling during 
response to chronic hypoxia 
Several lines of evidence indicate that reduced ion leakage is an important mechanism for 
energy conservation during extreme hypoxia, and adenosine has been implicated in ion 
channel activity. Precisely, it has been shown that A1 receptor stimulation inhibits the 
brain’s electrical activity through K+ channel activation (direct coupling via G-proteins to ion 
channels) and/or by inhibiting the high-voltage-activated Ca2+ channels (Fowler et al. 1999; 
Reshef et al. 2000). Extracellular adenosine plays a role in the reduction of K+ influx (channel 
arrest) that occurs in a brain that was subjected to chronic hypoxia(Reshef et al. 2000). 
Monitoring of the changes in extracellular K+ concentration (K+)o in the in-situ brain of the 
turtle (Trachemys scripta), following inhibition of Na+/K(+)-ATPase with ouabain revealed 
that  the time to reach full depolarization (K+)o plateau) was 3 times more in the chronic 
hypoxic brain than in normoxic controls (Pék  and Lutz 1997). The initial rate of K+ leakage 
was reduced by approximately 70%. Following  superfusing the brain, before the onset of 
chronic hypoxia with the non selective  adenosine receptor blocker, theophylline, or the 
specific adenosine A1 receptor blocker, 8-cyclopentyltheophylline, there was a significant 
reduction in the time to full depolarization in the ouabain-challenged  hypoxic-brain and an 
increase in  the rate of K+  efflux(Pék  and Lutz 1997). The results indicate that A1 receptors 
are involved in the expression of chronic hypoxia-induced ion channel arrest in the brain. 
This finding is supported by other studies that indicated that in a chronic hypoxic tolerant 
specie, the basic strategy for hypoxia survival is  the  maintenance of ion gradients to avoid 
anoxic depolarization (Lutz et al. 1996; Perez-Pinzon and Born 1999). To this extent, an 
important question that re-occurred in many of the most recent theoretical papers is how 
does hypoxia tolerant species respond to anoxia? In our physiological perspective of 
www.intechopen.com
 
Brain Injury – Pathogenesis, Monitoring, Recovery and Management 332 
hypoxia neuroprotection, adaption to anoxia (an extreme form of hypoxia) is mainly 
controlled by hypoxia/ischemic conditioning mechanism(Liu et al. 1991). In addition, the 
different physiological adaptations for extreme hypoxia have been well described in turtles, 
one of the species with a unique ability to tolerate extreme hypoxia. In humans, an extreme 
hypoxia condition causes major histopathological events to the brain. However, in turtles 
that have the ability to resist extreme form of hypoxia, tolerance is seen when a sublethal 
ischemic/anoxia insult is induced sometime before a lethal ischemic/anoxia insult is 
induced(Liu et al. 1991). The mechanisms involved are not well understood. Therefore, a 
better understanding of the mechanisms that induce extreme tolerance to hypoxia in turtles 
may provide novel therapeutic interventions that may aide human brain to resist the 
ravages of extreme hypoxia.  
6.1 Adenosine facilitates hypoxia neuroprotection by mediating intracellular signaling 
pathways 
Several lines of evidence indicate that severe hypoxia can cause an imbalance between 
oxygen supply and consumption. This is  usually accompanied by transportation of  
adenosine down its concentration gradient from the cell via nucleoside transporters, such as 
ENT1 and the ENT2. These transporters are equilibrative nucleoside transporters that are 
expressed in  the CNS (Chaudary et al. 2004b; Chaudary et al. 2004a), to promote the 
extracellular accumulation of adenosine. In this context, adenosine seems to act as an 
autocrine signal that indicates the disproportion between cellular oxygen availability and 
oxygen usage. Since adenosine is also an essential component of ATP synthesis, adenosine 
pools need to be vigilantly sustained in metabolically active cells in the brain. This could be 
done by minimizing extracellular release of adenosine, first by down-regulation of ENT 
activity. This would  aid the restoration of  ATP pools once the hypoxic stress has been 
removed. It is also important to point out that an ENT activity could lead to reuptake of 
extracellular adenosine to terminate receptor activation, as uniquely done by the 
neurotransmitter transporters to help restore intracellular pools of adenosine. The precise 
nature of the relationship between adenosine transporters, adenosine receptors and 
intracellular signaling pathways is not well known. Hypoxia is known to regulate the 
adenosine transporter mENT1 (inhibitor-sensitive), and protein kinase c q (PKCq) is 
involved in regulation of mENT1(Chaudary et al. 2004a), suggesting that chronic hypoxia 
regulates ENT1, both in terms of protein and overall reactivity through PKC-mediated 
hypoxia preconditioning. 
The PKC-mediated hypoxia protection occurs when extracellular adenosine interacts with 
adenosine receptors (A1, A2A, A2B, and/or A3), and activation of adenosine receptors 
stimulate signaling pathways that "resist" the stress caused by hypoxia (David et al. 2002). It 
then implies that the onset of hypoxia leads to a decrease in cellular ATP stores and 
subsequent generation of adenosine, which is then released extracellularly. An increase in 
adenosine levels, in addition to bradykinin and opioids, initiate a series of intracellular 
signaling events via G-protein-coupled receptor signaling leading to activation of PKC 
activation (Di-Capua et al. 2003). Several studies have shown that injections of adenosine 
could protect neuronal cells against hypoxic-type injury via a PKC-mediated mechanism 
(Dave et al. 2009). A series of intracellular signaling that leads to the adenosine-mediated 
PKC-induced mechanism of hypoxia protection include; i) adenosine stimulates G-protein–
coupled receptors, such as the A1/A3 adenosine receptors which activate phospholipases 
(phospholipase C; PLC) via G-proteins (Gi/o). ii) Other preconditioning stimulus, such as 
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extracellular glutamate stimulates NMDARs, leading to increased cytosolic calcium and 
PLC activation. iii) PKC is activated by PLC, and it increases di-acylglycerol (DAG) 
production, which in turn activates PKC isozymes including PKC. Finally, the PKC 
activation of extracellular signal-regulated kinase (ERK) promotes survival. Neuronal 
survival occurs because PKC may induce the opening of K (ATP) channels in the 
mitochondria (KATP) to regulate ATP production, and reduce generation of ROS. 
Interestingly, mitochondria are ideally located to serve as the cellular oxygen signal and 
mediator of protective mechanisms, such as ion channel arrest. Thus, regulation of 
mitochondria based mechanism of ion channel arrest involving ATP-sensitive mitochondrial 
K(+) channels, cytosolic calcium and ROS concentrations could contribute to neuronal 
survival. 
It is also very important to point out that adenosine-mediated PKC  signaling is mediated 
in part through ERK, a mitogen-activated protein kinase (MAPK) family member that has 
been implicated in antiapoptotic signaling(Lange-Asschenfeldt et al. 2004). ERK maintains 
mitochondrial function by inhibiting deleterious Bcl-2 associated death domain protein BAD 
activity(Qiu et al. 2001).Taken together, adenosine-mediated PKC signaling seems to 
activate ERK. This activation is involved in antiapoptotic signaling and cell survival during 
the induction of hypoxia preconditioning state, in order  to salvage ‘at-risk-tissue’ with 
residual energy levels. The role of adenosine-mediated PKC signaling in altering the 
expression or activity of calcium/calmodulin-dependent protein kinase II, MAPK family 
members, c-Jun N-terminal kinase, ERK, protein kinase B and PKC indicates that multiple 
kinases participate in the response of the tissue to counteract the effect of hypoxia (Obexer et 
al. 2006). This is important because PKC activity has been implicated in cell injury in the 
cerebral brain  (Bright et al. 2008)indicating that it could be involved in a conserved hypoxia 
response pathway. εPKC activation delays the collapse of ion homeostasis during ischemia 
in arctic ground squirrels(Dave et al. 2009). This finding suggests that εPKC mediates 26 
collapse of ion homeostasis in Arctic Ground Squirrels. This is possible  because εPKC 
inhibits both 27 Na(+)/K(+)-ATPase and voltage-gated sodium channels, which are primary 
mediators of 28 the collapse of ion homeostasis during ischemia in Arctic Ground Squirrel 
(Perez-Pinzon et 29 al. 2005). For this reason, the specific role of PKC in mediating 
hypoxia/ischemia-induced brain injury following the onset of stroke will be an interesting 
area of attention. Even more interesting is that the controversy  over whether  PKC mediates 
or is simply activated during hypoxia/ischemia-induced cell injury has been resolved to an 
extent by studies in ischemic models  that  suggest that PKC activity occurs via  PKC  that 
mediates adenosine-induced preconditioning via K+ATP function (Chaudary et al. 2004b; 
Bright et al. 2008). 
Several lines of evidence suggest that PKC can confer cerebral protection partly by 
maintaining mitochondrial function via ERK activity and by modulating adenosine-induced 
mK+ATP channel function. It is also possible that PKC activity inside the mitochondria may 
facilitate the regulation of mK+ATP channels, which is important for defending mitochondrial 
membrane potential and robust maintenance of ionic homeostasis. Recently, the role of 
PKC as a key mediator of neuroprotection was investigated (Teshima et al. 2003). Finding 
from this study  indicates that epsilonPKC inhibits both Na(+)/K(+)-ATPase and voltage-
gated sodium channels, which are primary mediators of the collapse of ion homeostasis 
during ischemia in Arctic Ground Squirrel. Their results support the hypothesis that PKC 
activation is neuroprotective by delaying the collapse of ion homeostasis during ischemia or 
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hypoxia. This probably involves robust maintenance of ion homeostasis, which leads to the 
conservation of energy by  plummeting calcium influx during metabolic challenges. In 
summary, studies exploring the specific signaling pathways in which PKC participates, 
including different downstream effectors in different phases of stroke injury will be 
significant to develop an adenosine-mediated PKC signaling therapeutic strategy for the 
clinical management of stroke patients. It is also important to emphasize that continuous 
cerebral blood flow, maintenance of cerebral oxygen tension and normal mitochondrial 
function are vital for the maintenance of brain function and tissue viability in the face of 
chronic hypoxia. The maintenance of normal brain functions require many parameters to 
work together and contribute to the homeostasis of brain energy demand and supply. Such 
a combination of parameters that could, in turn, lead to hypoxia protection include 
regulation of levels of inducible nitric oxide synthase (Thompson and Dong 2005; Thompson 
et al. 2009)and expression of HIF-1a(Trollmann and Gassmann 2009). Other parameters 
include the  activation of extracellular-signal-regulated kinase(Osorio-Fuentealba et al. 2009; 
Wilkerson and Mitchell 2009)and c-Jun N-terminal kinase/stress-activated protein kinases 
(Comerford et al. 2004). Understanding the central mechanism that regulates the 
combination of the parameters is necessary when developing new approaches to remedying 
hypoxia-induced brain injuries. This is because there is the possibility that a single central 
cellular mechanism could invoke a combination of parameters that could lead to the 
remarkable tolerance to hypoxia as seen in natural genetic models of hypoxia-tolerance. 
7. Conclusion 
Physiological mechanisms of hypoxia neuroprotection in natural systems of hypoxia 
tolerance represent the core of our understanding of how the brain of a stroke patient can be 
made to resist hypoxic insults. Our understanding of physiological adaptations associated 
with hypoxia tolerance in natural systems, and the diverse cellular implications of 
disrupting brain energy balance when oxygen delivery fails to meet demand provide the 
insights of how the human brain can be made tolerant to hypoxia. In this review, we suggest 
that the physiological mechanisms used by hypoxia-tolerant species offer clues on strategies 
to adapt for the clinical management of brain injuries where oxygen demand fails to match 
the supply.  
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